[What determines corticosteroid choice in a specific patient?].
作者信息
García Sánchez Valle, Iglesias Flores Eva, Gómez Camacho Federico
机构信息
Unidad Clínica de Aparato Digestivo, Hospital Universitario Reina Sofía, Córdoba, España.
出版信息
Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:27-37.
PMID:19087861
Abstract
摘要
相似文献
1
[What determines corticosteroid choice in a specific patient?].
Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:27-37.
2
[Systemic corticosteroids in inflammatory bowel disease: are they really effective. What is their real toxicity?].[全身用糖皮质激素治疗炎症性肠病：它们真的有效吗？其真正的毒性是什么？]
Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:3-9.
3
[Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?].[局部作用的皮质类固醇在炎症性肠病中的应用。它们有效吗？它们的毒性真的更低吗？]
Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:16-21.
4
[Locally acting corticosteroids in microscopic colitis: are they the treatment of choice? How should they be used?].[局部作用的皮质类固醇在显微镜下结肠炎中的应用：它们是首选治疗方法吗？应如何使用？]
Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:22-6.
5
[Acute episode].[急性发作]
Z Gastroenterol. 2003 Jan;41(1):27-30. doi: 10.1055/s-2003-36664.
6
Uses, adverse effects of abuse of corticosteroids. Part II.皮质类固醇的用途、滥用的不良反应。第二部分。
Allergol Immunopathol (Madr). 1995 Jan-Feb;23(1):2-15.
7
[Chronic inflammatory bowel diseases. Update on evidence-based therapy].[慢性炎症性肠病。循证治疗的最新进展]
MMW Fortschr Med. 2005 Apr 28;147(17):58-9.
8
Anesthetic implications for patients receiving exogenous corticosteroids.接受外源性皮质类固醇治疗的患者的麻醉注意事项。
AANA J. 2006 Apr;74(2):133-9.
9
Budesonide for Crohn's disease.布地奈德用于克罗恩病
Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):971-9. doi: 10.1517/17425250903124355.
10
[Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
Nervenarzt. 1994 Feb;65(2):148.
Zotero 插件